Saturday, August 18, 2018 6:21:11 PM
IMO I think plenty of time left for BIEL to go down... weeks, not months though. I admit them entering this FDA challenge does adjust the potential time of things here. Kudos to them for getting that done.
I trade options a lot too. Selling premium is best, IMO. But one thing you learn is people like to have a ticket for the big event. Typically that event is an ER on a big or popular company like AMZN, AAPL, TWTR, TSLA, NFLX, FB, etc. In this case, the event is "FDA Clearance". Don't get me wrong... I am long BIEL (for possible post-clearance buyout)... but I am concerned with the seemingly lack of interest/new buyers when I am trying to sell relatively small lots like 5-10mln and they sit there half the day getting nibbled at. We all "know" that big event is coming soon for BIEL, right? The foretold "Imminent Tsunami" and all of this... LOL. So where are the buyers? Or have we already told all our friends, relatives, co-workers and customers about the wonderful opportunities here? ;)
Weak buyers?
You know who I personally think could or should be a strong buyer for the right price? BAYER. Simply because it would be a beautiful heaven-made match for the company behind Aspirin to lead the way for a next-generation pain management solution. That, and BAYER apparently already knows BIEL exists, who they are, and where they work etc.... to me that's half the battle to getting bought out right there IMO.
And let's be serious... how much longer is AJW going to do this? Why not get crazy money, settle/pay off SEC complaint or whatever (if that's possible?), and have mad millions leftover for generations of Whelans to come.
Or... would we rather do stupid stuff like this:
https://www.reevesbusinessreview.com/bioelectronics-corporation-otcpkbiels-mf-rank-of-16443-how-does-it-stack-up/
Or these 2 page "articles of amendments"...
https://egov.maryland.gov/businessexpress/EntitySearch/OrderDocuments/D05750989?ImageError=error&ErrorCode=1&FilingNumber=1000362011335058
I mean get real. If Bayer isn't offering, I'd be reading this saying "Jay has a point about Bayer/Aspirin being a good match..." and trying to sell them on buyout rather than footbed partnerships or whatever the worst-case scenario "deal" could or would be.
Messages are my own opinions. Assume I have a position or am considering one in any stock I am discussing. Do your own due-diligence. If I'm wrong please correct me so I can learn!
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM